Wall Street expects a year-over-year increase in earnings on higher revenues when Affiliated Managers Group (AMG) reports results for the quarter ended December 2025. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.The earnings report might help the stock move higher if these key numbers are better than expectations. On the other hand, if they m ...

Core Viewpoint - Cencora (COR) is expected to report strong first-quarter fiscal 2026 results, with positive revenue and earnings growth driven by pharmaceutical utilization trends and specialty-focused assets [1][3][7] Group 1: Financial Estimates - The Zacks Consensus Estimate for revenues is $85.97 billion, reflecting a 5.5% increase from the prior-year quarter [2] - The consensus estimate for earnings is $4.05 per share, indicating an 8.6% improvement from the previous year's figure [2] Group 2: Performance Drivers - Cencora's performance is anticipated to be supported by strong drug volumes and the U.S. Healthcare Solutions segment, which is expected to be the primary earnings driver [3][5][7] - The integration of Retina Consultants of America (RCA) is likely to contribute positively to sales and margins [3][4] Group 3: Segment Analysis - The U.S. Healthcare Solutions segment is projected to generate sales of $76.72 billion, benefiting from specialty distribution and MSO platforms [6][7] - The International Healthcare Solutions segment is expected to maintain growth, with sales estimated at $7.45 billion, supported by stable trends in Europe and World Courier momentum [6][8] Group 4: Margin and Growth Outlook - Margin performance is expected to remain favorable due to mix benefits from specialty distribution and MSO-related services, despite higher interest expenses from acquisition financing [4][5] - Specialty utilization, particularly in Part B drugs, is anticipated to support above-trend operating income growth [5]

Core Insights - Johnson Controls International plc (JCI) is a leading company in engineering, manufacturing, and retrofitting building products and systems, with a market capitalization of $71.6 billion [1] Performance Overview - JCI shares have outperformed the broader market over the past year, increasing by 53.4%, while the S&P 500 Index rose by 15% [2] - In 2026, JCI's stock has declined nearly 2.5%, underperforming the S&P 500's 1.9% increase [2] Earnings Report - On November 5, JCI's stock surged by 8.8% following a better-than-expected Q4 2025 earnings release, with total revenue growing 3.1% year over year to $6.4 billion, exceeding Wall Street estimates [4] - The adjusted EPS for the quarter was $1.26, beating estimates by 5% [4] Future Projections - Analysts expect JCI's EPS to rise by 21.5% year over year to $4.57 for the current year ending in September [5] - JCI has a solid earnings surprise history, surpassing consensus estimates in each of the last four quarters [5] Analyst Ratings - Among 20 analysts covering JCI, the consensus rating is a "Moderate Buy," consisting of 12 "Strong Buy" ratings and eight "Holds" [5] - The configuration has turned slightly bullish, with 12 "Strong Buy" ratings, up from 11 [6] - Morgan Stanley analyst Chris Snyder maintained an "Overweight" rating and raised the price target from $125 to $130, with a mean price target of $133.53 suggesting a 14.4% upside potential [6]

Core Viewpoint - VF Corp (NYSE:VFC) is a significant player in the apparel and footwear industry, with Goldman Sachs maintaining a Neutral rating and raising its price target from $16 to $18 while advising investors to hold their positions [1][5]. Financial Performance - VF Corp reported strong third-quarter earnings, with earnings of $0.58 per share, exceeding the FactSet consensus of $0.45 [2][5]. - Revenue increased by 1.5% year-over-year, reaching $2.88 billion, surpassing analysts' estimates of $2.75 billion, driven by a successful holiday season for The North Face and Timberland [2][5]. - The company's gross margin improved by 30 basis points to 56.6%, aided by a favorable product mix and sourcing savings that offset tariff impacts [3]. - Operating income rose to $289 million, up from $226 million the previous year [3][5]. Stock Performance - VF Corp's stock price is currently at $19.11, having decreased by 5.77% or $1.17 recently [4]. - The stock has traded between a low of $17.80 and a high of $19.23 on the current day, with a yearly high of $29.02 and a low of $9.41 [4]. - The company's market capitalization is approximately $7.47 billion, with a trading volume of 19,049,705 shares on the NYSE [4].

Core Insights - Conmed (CNMD) reported revenue of $373.2 million for the quarter ended December 2025, marking a year-over-year increase of 7.9% and an EPS of $1.43 compared to $1.34 a year ago, exceeding the Zacks Consensus Estimate of $366.22 million by 1.91% [1] Financial Performance - The company delivered an EPS surprise of 8.61%, with the consensus EPS estimate being $1.32 [1] - Conmed's shares have returned -3.8% over the past month, while the Zacks S&P 500 composite increased by 0.8%, indicating potential underperformance in the near term with a Zacks Rank of 5 (Strong Sell) [3] Revenue Breakdown - Domestic revenue was $206.2 million, slightly above the average estimate of $205.31 million, reflecting a year-over-year change of 1.4% [4] - International revenue reached $167 million, surpassing the average estimate of $160.92 million, with a year-over-year increase of 17.1% [4] - Net sales in Orthopedic Surgery were $157.4 million, exceeding the estimated $147.41 million, representing a 13.2% year-over-year change [4] - Net sales for Capital Products were $52.6 million, slightly below the estimated $53.13 million, with an 8.2% year-over-year increase [4] - Net sales of Single-use Products totaled $320.6 million, above the average estimate of $313.1 million, reflecting a 7.8% year-over-year change [4] - Net sales in General Surgery were $215.8 million, below the estimated $218.82 million, with a year-over-year increase of 4.3% [4]

分组1 - Axis Capital reported quarterly earnings of $3.25 per share, exceeding the Zacks Consensus Estimate of $2.97 per share, and showing an increase from $2.97 per share a year ago, resulting in an earnings surprise of +9.43% [1] - The company achieved revenues of $1.72 billion for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 5.16%, compared to revenues of $1.58 billion in the same quarter last year [2] - Axis Capital has consistently surpassed consensus EPS estimates over the last four quarters, achieving this four times [2] 分组2 - The stock has underperformed the market, losing about 4.3% since the beginning of the year, while the S&P 500 has gained 1.9% [3] - The current consensus EPS estimate for the upcoming quarter is $2.93 on revenues of $1.6 billion, and for the current fiscal year, it is $12.70 on revenues of $6.75 billion [7] - The Zacks Industry Rank for Insurance - Property and Casualty is currently in the bottom 37% of over 250 Zacks industries, indicating potential challenges for the sector [8]

Core Insights - Ormat Technologies (ORA) has consistently beaten earnings estimates, with an average surprise of 20.27% over the last two quarters [1] Earnings Performance - For the last reported quarter, Ormat Technologies achieved earnings of $0.41 per share, surpassing the Zacks Consensus Estimate of $0.37 per share, resulting in a surprise of 10.81% [2] - In the previous quarter, the company was expected to post earnings of $0.37 per share but delivered $0.48 per share, leading to a surprise of 29.73% [2] Earnings Estimates and Predictions - Estimates for Ormat Technologies have been trending higher, influenced by its history of earnings surprises [5] - The company currently has a positive Earnings ESP of +1.25%, indicating that analysts are optimistic about its earnings prospects [8] - The combination of a positive Earnings ESP and a Zacks Rank of 3 (Hold) suggests a strong possibility of another earnings beat in the upcoming report [8] Statistical Insights - Research indicates that stocks with a positive Earnings ESP and a Zacks Rank of 3 or better have a nearly 70% chance of producing a positive surprise [6] - The Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate, with the Most Accurate Estimate reflecting the latest analyst revisions [7]

Core Viewpoint - Piper Sandler Companies (PIPR) has a strong history of beating earnings estimates and is well-positioned for future earnings surprises, particularly with an average surprise of 38.65% over the last two quarters [1][5]. Earnings Performance - For the most recent quarter, Piper Sandler reported earnings of $3.82 per share, exceeding the expected $2.96 per share by a surprise of 29.05% [2]. - In the previous quarter, the company reported $2.95 per share against an estimate of $1.99 per share, resulting in a surprise of 48.24% [2]. Earnings Estimates and Predictions - Estimates for Piper Sandler have been trending higher, supported by its history of earnings surprises [5]. - The company currently has an Earnings ESP of +1.06%, indicating a bullish outlook from analysts regarding its earnings prospects [8]. - The combination of a positive Earnings ESP and a Zacks Rank of 3 (Hold) suggests a high likelihood of another earnings beat in the upcoming report [8]. Statistical Insights - Research indicates that stocks with a positive Earnings ESP and a Zacks Rank of 3 or better have a nearly 70% chance of producing a positive surprise [6]. - The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate, reflecting the latest analyst revisions [7].

Core Insights - Applied Industrial Technologies, Inc. (AIT) reported Q2 fiscal 2026 earnings of $2.51 per share, exceeding the Zacks Consensus Estimate of $2.48, marking a 4.6% year-over-year increase [1][9] - Net revenues reached $1.16 billion, slightly missing the consensus estimate of $1.17 billion, but reflecting an 8.4% year-over-year growth [2][9] Revenue Breakdown - The Service Center-Based Distribution segment generated revenues of $747.3 million, accounting for 64.3% of total revenues, with a year-over-year increase of 3.2% [3] - The Engineered Solutions segment, contributing 35.7% to net revenues, reported revenues of $415.7 million, up 19.1% year-over-year, driven by acquisitions and pricing gains [4] Margin and Cost Analysis - AIT's cost of sales increased by 8.7% year-over-year to $809.7 million, while gross profit rose 7.7% to $353.3 million, resulting in a slight decrease in gross margin to 30.4% [5] - Selling, distribution, and administrative expenses increased by 11.1% year-over-year to $230.1 million, with EBITDA rising 3.9% to $140.4 million [5] Balance Sheet and Cash Flow - As of the first six months of fiscal 2026, AIT had cash and cash equivalents of $406 million, up from $388.4 million at the end of fiscal 2025, with long-term debt remaining stable at $572.3 million [6] - The company generated net cash of $219 million from operating activities, a decrease of 1.7% year-over-year, while capital expenditures rose 27.1% to $13.6 million [7] Dividend and Shareholder Returns - AIT announced an 11% increase in its quarterly dividend to 51 cents per share, marking the 17th dividend hike since 2010 [8][9] Future Guidance - For fiscal 2026, AIT anticipates adjusted earnings in the range of $10.45-$10.75 per share and expects sales growth of 5.5-7%, with an organic growth forecast of 2.5-4% [10]

Core Viewpoint - The market anticipates a year-over-year decline in Ezcorp's earnings despite an increase in revenues for the quarter ending December 2025, with actual results being crucial for stock price movement [1][2]. Earnings Expectations - Ezcorp is expected to report quarterly earnings of $0.40 per share, reflecting a year-over-year decrease of 4.8%, while revenues are projected to reach $345 million, an increase of 7.8% from the previous year [3]. Estimate Revisions - The consensus EPS estimate has remained unchanged over the last 30 days, indicating that analysts have not significantly altered their initial projections during this period [4]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that the Most Accurate Estimate for Ezcorp aligns with the Zacks Consensus Estimate, resulting in an Earnings ESP of 0%, suggesting no recent differing analyst views [12]. Historical Performance - Ezcorp has consistently beaten consensus EPS estimates in the past four quarters, with the last reported quarter showing an earnings surprise of +17.24% [13][14]. Investment Considerations - Despite the historical performance, Ezcorp does not currently appear to be a strong candidate for an earnings beat, and investors should consider other factors before making investment decisions [17].